SCHEMBL7093262

SCHEMBL7093262

Nc1ccc(S(=O)(=O)Nc2ccon2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.59
ADRA1A P35348 2/20 0.59
ALDH1A1 P00352 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 4/20 0.53
KDM4E B2RXH2 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
HTR6 P50406 4/20 0.50
CYP2C19 P33261 3/20 0.50
CYP2C9 P11712 3/20 0.50
EDNRA P25101 2/20 0.50
TSHR P16473 2/20 0.50
KMT2A Q03164 2/20 0.50
PDE4A P27815 1/20 0.50
AGO2 Q9UKV8 1/20 0.50
AURKA O14965 1/20 0.50
DHFR P00374 1/20 0.50
MEN1 O00255 1/20 0.50
EDNRB P24530 1/20 0.50
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11661462 0.98 MAPT (0.57) MAPTADRA1AALDH1A1SMN1; SMN2LMNA
SCHEMBL23440267 0.83 KDM4E (0.51) MAPTALDH1A1SMN1; SMN2KDM4ENPSR1
SCHEMBL3477694 0.83 BRD4 (0.52) ALDH1A1KDM4EEDNRATSHRKMT2A
SCHEMBL11651032 0.81 POLB (0.55) MAPTADRA1AALDH1A1SMN1; SMN2LMNA
SCHEMBL11661464 0.81 POLB (0.55) MAPTADRA1AALDH1A1SMN1; SMN2LMNA
SCHEMBL7243110 0.81 MAPK1 (0.61) MAPTEDNRATSHRKMT2AMEN1
SCHEMBL1390671 0.80 EDNRB (0.53) MAPTALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL8065463 0.79 ALDH1A1 (0.48) MAPTADRA1AALDH1A1KDM4EEDNRA
SCHEMBL5564296 0.78 CA12 (0.54) MAPTALDH1A1SMN1; SMN2LMNACYP2C9
SCHEMBL28575287 0.78 SCN9A (0.41) ALDH1A1KDM4EKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6638921-B1 Pharmaceutically acceptable derivatives thereof Cx, R1 and R2 being as defined in the disclosure may be used to inhibit the activity of HIV integrase. PHARMACOR INC. (CA) 2003-10-28 US disclosed
WO-2003082881-A2 PYRIDOXAL-5-PHOSPHATE DERIVATIVES AS HIV INTEGRASE INHIBITORS PROCYON BIOPHARMA INC. (CA) 2003-10-09 WO disclosed
US-4172079-A Preparation of 4-nitroisoxazoles TEXACO INC. (US) 1979-10-23 US disclosed
US-4102806-A DISPERSION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1978-07-25 US disclosed